Formats: Text / Subjects: Antineoplastic Agents - Digital Collections - National Library of Medicine Search Results

Start Over Formats Text ✖ Subjects Antineoplastic Agents ✖

1. The treatment of malignant tumors by the toxins of the streptococcus of erysipelas

Author(s):: Senn, Nicholas, 1844-1908
Publication:: Chicago : American Medical Association Press, 1895
Subject(s):: Erysipelas -- microbiology
Streptococcus
Antineoplastic Agents

2. Medication errors in outpatient hematology and oncology clinics

Author(s):: Banasser, Ghadeer, author
Karpow, Celeste, author
Gaunt, Michael J., author
Grissinger, Matthew, author
Publication:: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, December 2017
Subject(s):: Ambulatory Care Facilities -- statistics & numerical data
Hematology
Medical Oncology
Medication Errors -- statistics & numerical data
Adrenal Cortex Hormones
Antineoplastic Agents
Colony-Stimulating Factors
Risk Management
Humans
Pennsylvania
United States

3. Expansion cohorts: use in first-in-human clinical trials to expedite development of oncology drugs and biologics

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2022
Subject(s):: Antineoplastic Agents
Biological Products
Clinical Trials as Topic
Drug Development -- legislation & jurisprudence
Drug Development -- standards
Medical Oncology
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

4. Master protocols: efficient clinical trial design strategies to expedite development of oncology drugs and biologics

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2022
Subject(s):: Antineoplastic Agents
Biological Products
Clinical Trial Protocols as Topic
Clinical Trials as Topic
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

5. Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
Subject(s):: Double-Blind Method
Neoplasms -- drug therapy
Placebos
Randomized Controlled Trials as Topic -- standards
Single-Blind Method
Antineoplastic Agents
Biological Products
Randomized Controlled Trials as Topic -- ethics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

6. Oncology drug products used with certain in vitro diagnostic tests: pilot program : guidance for industry, clinical laboratories, and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, June 20, 2023
Subject(s):: Antineoplastic Agents
Drug Industry
Government Regulation
In Vitro Techniques
United States
United States. Food and Drug Administration